Steph & Co’s Quest Diagnostics DGX Stock Holding History

Steph & Co’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$814K	Sell	3,492 -404	-10%	-$93.4K	0.21%	42
2026 Q2	$826K	Buy	3,896 +643	+20%	+$126K	0.21%	41
2026 Q1	$638K	Buy	3,253 +18	+0.6%	+$3.5K	0.18%	45
2025 Q4	$561K	Sell	3,235 -453	-12%	-$82.5K	0.16%	46
2025 Q3	$703K	Sell	3,688 -690	-16%	-$122K	0.21%	40
2025 Q2	$786K	Sell	4,378 -41	-0.9%	-$7.12K	0.26%	38
2025 Q1	$748K	Sell	4,419 -383	-8%	-$62.9K	0.27%	38
2024 Q4	$724K	Sell	4,802 -132	-3%	-$20.5K	0.24%	40
2024 Q3	$766K	Buy	4,934 +84	+2%	+$12.5K	0.24%	39
2024 Q2	$664K	Sell	4,850 -289	-6%	-$39.6K	0.23%	43
2024 Q1	$684K	Buy	+5,139	New	+$667K	0.24%	43

Other funds holding DGX

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Braun Stacey Associates New York $3.48B AUM 48.73% 1-Year Est. Return

Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return

Boston Common Asset Management Boston, Massachusetts $1.72B AUM 26.04% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

JGP Wealth Management Bend, Oregon $1.13B AUM 26% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Steph & Co's DGX Position: Q3 2026 in Review

Steph & Co reduced its Quest Diagnostics (DGX) stake by 10% in Q3 2026, selling an estimated $93.4K and leaving 3,492 shares worth $814K. The position accounts for 0.21% of the portfolio, ranked #42.

Steph & Co first reported a position in DGX in Q1 2024 and has held it in 11 quarters since. The position peaked at $826K in Q2 2026. 165 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

Steph & Co held 3,492 shares of Quest Diagnostics worth $814K as of Q3 2026.
Steph & Co sold 404 Quest Diagnostics shares in Q3 2026, an estimated $93.4K.
Quest Diagnostics made up 0.21% of Steph & Co's portfolio in Q3 2026, its #42 holding.
Steph & Co first reported a position in Quest Diagnostics in Q1 2024 and has held it in 11 quarters since.
Steph & Co's Quest Diagnostics position peaked at $826K in Q2 2026.
165 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Steph & Co's 13F filing for Q3 2026, filed 7 Oct 2026.